From 2022 to 2029, the global counterfeit drug detection devices market is predicted to grow significantly at a 4.0% CAGR, with a market value of approximately US$ 1.14 billion in 2022. According to Future Market Insights’ forecasts, counterfeit chemical composition detection devices will hold a sizable market share.
The global Counterfeit Drug Detection Device Market is predicted to develop at a 4.0% CAGR from 2022 to 2029, with a market value of roughly US$ 1.14 billion in 2022. According to Future Market Insights, counterfeit chemical composition detection devices will account for approximately 60.6% of the global market in 2.
Counterfeit drugs are substandard and falsified drugs and it is a global problem. Counterfeit Drug Detection Devices are the medical devices that are used to detect the counterfeit chemical composition of the drugs and counterfeit packaging and labeling of the drug. The WHO defines a counterfeit drug as any pharmace.
Counterfeit drugs are substandard and falsified drugs and it is a global problem. Counterfeit Drug Detection Devices are the medical devices that are used to detect the counterfeit chemical composition of the drugs and counterfeit packaging and labeling of the drug. The WHO defines a counterfeit drug as any pharmace.
Search jobs 21-Dec-2020 Counterfeit Drug Detection Device Market Revenue to Decline During Coronavirus Disruption, Stakeholders to Realign Their Growth Strategies
VALLEY COTTAGE, N.Y. – Counterfeit drugs are substandard and falsified drugs and it is a global problem. Counterfeit Drug Detection Devices are the medical devices that are used to detect the counterfeit chemical composition of the drugs and counterfeit packaging and labeling of the drug. The WHO defines a counterfeit drug as any pharmaceutical product that is deliberately mislabeled with respect to identity and/or source. Counterfeit drugs may include branded and generic products, drugs with the correct ingredients or with the wrong ingredients; without active pharmaceutical ingredient (API), with insufficient active pharmaceutical ingredients (API) or with fake packaging (WHO 2012).